Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Mesoporous silica nanoparticles co-loaded with lysozyme and vancomycin for synergistic antimicrobial action
by
Nayeri Fasaei, Bahar
, Joghataei, Seyed Mehdi
, Shariati, Parvin
, Arpanaei, Ayyoob
, Namdar, Nasrin
in
631/326
/ 631/326/22
/ 631/326/22/1290
/ 631/326/22/1294
/ 631/326/22/1434
/ 631/326/41
/ 639/925
/ 639/925/350
/ 639/925/352
/ 639/925/352/152
/ Anti-Bacterial Agents - administration & dosage
/ Anti-Bacterial Agents - chemistry
/ Anti-Bacterial Agents - pharmacology
/ Antibacterial activity
/ Antibiotics
/ Antimicrobial activity
/ Antimicrobial agents
/ Bacterial diseases
/ Biocompatibility
/ Cell Line
/ Cell lines
/ Cell Survival - drug effects
/ Cell viability
/ Combination therapy
/ Cytotoxicity
/ Drug Carriers - chemistry
/ Drug Synergism
/ Hemolysis - drug effects
/ Humanities and Social Sciences
/ Humans
/ Lysozyme
/ Microbial Sensitivity Tests
/ Minimum inhibitory concentration
/ MSNs
/ multidisciplinary
/ Muramidase - pharmacology
/ Nanoparticles
/ Nanoparticles - chemistry
/ Nanotechnology
/ Porosity
/ Science
/ Science (multidisciplinary)
/ Silica
/ Silicon Dioxide - chemistry
/ Staphylococcus aureus - drug effects
/ Vancomycin
/ Vancomycin - administration & dosage
/ Vancomycin - chemistry
/ Vancomycin - pharmacology
2024
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Mesoporous silica nanoparticles co-loaded with lysozyme and vancomycin for synergistic antimicrobial action
by
Nayeri Fasaei, Bahar
, Joghataei, Seyed Mehdi
, Shariati, Parvin
, Arpanaei, Ayyoob
, Namdar, Nasrin
in
631/326
/ 631/326/22
/ 631/326/22/1290
/ 631/326/22/1294
/ 631/326/22/1434
/ 631/326/41
/ 639/925
/ 639/925/350
/ 639/925/352
/ 639/925/352/152
/ Anti-Bacterial Agents - administration & dosage
/ Anti-Bacterial Agents - chemistry
/ Anti-Bacterial Agents - pharmacology
/ Antibacterial activity
/ Antibiotics
/ Antimicrobial activity
/ Antimicrobial agents
/ Bacterial diseases
/ Biocompatibility
/ Cell Line
/ Cell lines
/ Cell Survival - drug effects
/ Cell viability
/ Combination therapy
/ Cytotoxicity
/ Drug Carriers - chemistry
/ Drug Synergism
/ Hemolysis - drug effects
/ Humanities and Social Sciences
/ Humans
/ Lysozyme
/ Microbial Sensitivity Tests
/ Minimum inhibitory concentration
/ MSNs
/ multidisciplinary
/ Muramidase - pharmacology
/ Nanoparticles
/ Nanoparticles - chemistry
/ Nanotechnology
/ Porosity
/ Science
/ Science (multidisciplinary)
/ Silica
/ Silicon Dioxide - chemistry
/ Staphylococcus aureus - drug effects
/ Vancomycin
/ Vancomycin - administration & dosage
/ Vancomycin - chemistry
/ Vancomycin - pharmacology
2024
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Mesoporous silica nanoparticles co-loaded with lysozyme and vancomycin for synergistic antimicrobial action
by
Nayeri Fasaei, Bahar
, Joghataei, Seyed Mehdi
, Shariati, Parvin
, Arpanaei, Ayyoob
, Namdar, Nasrin
in
631/326
/ 631/326/22
/ 631/326/22/1290
/ 631/326/22/1294
/ 631/326/22/1434
/ 631/326/41
/ 639/925
/ 639/925/350
/ 639/925/352
/ 639/925/352/152
/ Anti-Bacterial Agents - administration & dosage
/ Anti-Bacterial Agents - chemistry
/ Anti-Bacterial Agents - pharmacology
/ Antibacterial activity
/ Antibiotics
/ Antimicrobial activity
/ Antimicrobial agents
/ Bacterial diseases
/ Biocompatibility
/ Cell Line
/ Cell lines
/ Cell Survival - drug effects
/ Cell viability
/ Combination therapy
/ Cytotoxicity
/ Drug Carriers - chemistry
/ Drug Synergism
/ Hemolysis - drug effects
/ Humanities and Social Sciences
/ Humans
/ Lysozyme
/ Microbial Sensitivity Tests
/ Minimum inhibitory concentration
/ MSNs
/ multidisciplinary
/ Muramidase - pharmacology
/ Nanoparticles
/ Nanoparticles - chemistry
/ Nanotechnology
/ Porosity
/ Science
/ Science (multidisciplinary)
/ Silica
/ Silicon Dioxide - chemistry
/ Staphylococcus aureus - drug effects
/ Vancomycin
/ Vancomycin - administration & dosage
/ Vancomycin - chemistry
/ Vancomycin - pharmacology
2024
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Mesoporous silica nanoparticles co-loaded with lysozyme and vancomycin for synergistic antimicrobial action
Journal Article
Mesoporous silica nanoparticles co-loaded with lysozyme and vancomycin for synergistic antimicrobial action
2024
Request Book From Autostore
and Choose the Collection Method
Overview
Nanotechnology offers a novel strategy for enhancing the susceptibility of pathogens resistant to traditional antibiotics. Another effective strategy is combination therapy, where multiple agents are used together to improve treatment efficacy. In this study, both nanoparticle-based formulation and combinatorial therapy were utilized to develop a potent antibacterial system targeting infectious bacteria. Lysozyme (Lys) and Vancomycin (Van) were co-loaded onto mesoporous silica nanoparticles (MSNs), forming Lys-Van-MSNs. The antimicrobial activity of these nanoparticles was evaluated by determining the minimum inhibitory concentration (MIC) against
Staphylococcus aureus
. The MIC values for Lys-Van-MSNs were 0.85 µg/ml for Van and 0.168 mg/ml for Lys, reflecting reductions of 86.4% and 93.7%, respectively, compared to the free forms. Additionally, cytotoxicity was tested using MTT, ROS, and hemolysis assays on human cell lines (breast, fibroblast, and AGS), showing over 80% cell viability, indicating minimal toxicity. The MSN-based formulation, with its synergistic antibacterial effects, reduced drug dosage, and high biocompatibility, offers a practical and effective solution for addressing bacterial infections.
Publisher
Nature Publishing Group UK,Nature Publishing Group,Nature Portfolio
Subject
/ 639/925
/ Anti-Bacterial Agents - administration & dosage
/ Anti-Bacterial Agents - chemistry
/ Anti-Bacterial Agents - pharmacology
/ Cell Survival - drug effects
/ Humanities and Social Sciences
/ Humans
/ Lysozyme
/ Minimum inhibitory concentration
/ MSNs
/ Porosity
/ Science
/ Silica
/ Staphylococcus aureus - drug effects
This website uses cookies to ensure you get the best experience on our website.